Search - tctmd.com

Displaying 881 - 900 of 2735

Sort: Relevancy | Date

Presentation TVT 2017

Endogenous Tissue Restoration: Preclinical Investigation With Bioresorbable, Pulmonary, and Aortic Valves

Presenter: Patrick W. Serruys

June 16, 2017

Presentation TVT 2017

Prevalence of Amyloid in Patients Undergoing TAVR: Low-Flow Phenotype and Echocardiographic Predictors

Presenter: David J. Cohen, Mark J. Russo, Adam Castano

June 16, 2017

Presentation TVT 2017

Percutaneous Transcatheter Aortic Valve Closure to Treat Left Ventricular Assist Device-Associated Aortic Regurgitation

Presenter: Shigeru Saito, Jonathon M. White, Abdullah Alenezi, MD

June 16, 2017

Presentation TVT 2017

The Self-Expanding Single-Operator CENTERA TAVR System

Presenter: Didier Tchetche

June 16, 2017

Presentation TVT 2017

TAVR to Treat Aortic Regurgitation in LVAD Patients Rationale and Case Examples

Presenter: David J. Cohen, Mark J. Russo, Nir Uriel

June 16, 2017

Presentation TVT 2017

Potential Role of Outer Skirt of SAPIEN-3 Valve for Annular Rupture

Presenter: Shigeru Saito, Jonathon M. White, Mike Saji, MD

June 16, 2017

Presentation TVT 2017

The Future Role of Tissue Engineered Aortic Valves for TAVR (and SAVR)

Presenter: A. Pieter Kappetein

June 16, 2017

Presentation TVT 2017

Emergent TAVR for AS Patients With Intractable Heart Failure: Feasibility and Early Clinical Results

Presenter: David J. Cohen, Mark J. Russo, Ran Kornowski

June 16, 2017

Presentation TVT 2017

Lotus Aortic Valve Replacement in a Patient With Severe Aortic Valve Calcification: Making a Difference in TAVR

Presenter: Shigeru Saito, Jonathon M. White, Naseer Khan, MD

June 16, 2017

Presentation TVT 2017

The Venus A-Valve and Venibri TAVR Systems Better for Bicuspids and Dry Leaflet Technology

Presenter: Horst Sievert

June 16, 2017

Presentation TVT 2017

Who Shouldnt Undergo TAVR? Can We Identify Non-responders?

Presenter: David J. Cohen, Mark J. Russo, Suzanne V. Arnold

June 16, 2017

Presentation TVT 2017

Pitfalls in TAVR for Failing Stentless St. Jude Toronto 27mm Bioprosthetic AVR With Severe Aortic Insufficiency and No Significant Valvular Calcification

Presenter: Shigeru Saito, Jonathon M. White, Johannes Brechtken, MD

June 16, 2017

Presentation TVT 2017

The Anatomically Correct JenaValve TAVR System Pure AR Treatment

Presenter: Hendrik Treede

June 16, 2017

Presentation TVT 2017

Threatened Left Main Avoid, Pre-Emptive Planning, or React as Needed

Presenter: John K. Forrest, James M. McCabe, Jean-Michel Paradis

June 16, 2017

Presentation TVT 2017

Ineffective Endocarditis After TAVR: Cause for Concern?

Presenter: David J. Cohen, Mark J. Russo, Bernard Prendergast

June 16, 2017

Presentation TVT 2017

Percutaneous Use of Septal Occluder for Management of Aortic Insufficiency Post-Left Ventricular Assist Device

Presenter: Shigeru Saito, Jonathon M. White, Sidakpal Panaich, MD

June 16, 2017

Presentation TVT 2017

Inadequate Femoral Access All Roads Lead to Rome

Presenter: John K. Forrest, James M. McCabe, Adam B. Greenbaum

June 16, 2017

Presentation TVT 2017

Gender Differences in TAVR Outcomes Recent Analyses in Intermediate-Risk Patients

Presenter: David J. Cohen, Mark J. Russo, Molly Szerlip

June 16, 2017

Presentation TVT 2017

Sizing in the Gray Zone

Presenter: John K. Forrest, James M. McCabe, Christopher U. Meduri

June 16, 2017

Presentation TVT 2017

Featured Lecture: Managing the AS Patient With a Small Aortic Annulus- Implications of Patient-Prosthesis Mismatch and TAVR Alternatives

Presenter: Shigeru Saito, Jonathon M. White, Philippe Pibarot

June 16, 2017

Advertisement

Endogenous Tissue Restoration: Preclinical Investigation With Bioresorbable, Pulmonary, and Aortic Valves

Prevalence of Amyloid in Patients Undergoing TAVR: Low-Flow Phenotype and Echocardiographic Predictors

Percutaneous Transcatheter Aortic Valve Closure to Treat Left Ventricular Assist Device-Associated Aortic Regurgitation

The Self-Expanding Single-Operator CENTERA TAVR System

TAVR to Treat Aortic Regurgitation in LVAD Patients Rationale and Case Examples

Potential Role of Outer Skirt of SAPIEN-3 Valve for Annular Rupture

The Future Role of Tissue Engineered Aortic Valves for TAVR (and SAVR)

Emergent TAVR for AS Patients With Intractable Heart Failure: Feasibility and Early Clinical Results

Lotus Aortic Valve Replacement in a Patient With Severe Aortic Valve Calcification: Making a Difference in TAVR

The Venus A-Valve and Venibri TAVR Systems Better for Bicuspids and Dry Leaflet Technology

Who Shouldnt Undergo TAVR? Can We Identify Non-responders?

Pitfalls in TAVR for Failing Stentless St. Jude Toronto 27mm Bioprosthetic AVR With Severe Aortic Insufficiency and No Significant Valvular Calcification

The Anatomically Correct JenaValve TAVR System Pure AR Treatment

Threatened Left Main Avoid, Pre-Emptive Planning, or React as Needed

Ineffective Endocarditis After TAVR: Cause for Concern?

Percutaneous Use of Septal Occluder for Management of Aortic Insufficiency Post-Left Ventricular Assist Device

Inadequate Femoral Access All Roads Lead to Rome

Gender Differences in TAVR Outcomes Recent Analyses in Intermediate-Risk Patients

Sizing in the Gray Zone

Featured Lecture: Managing the AS Patient With a Small Aortic Annulus- Implications of Patient-Prosthesis Mismatch and TAVR Alternatives

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content